FMT from aged APP/PS1 mice into wild-type mice resulted in elevated gut BACE1 and Aβ42 levels, which triggered neuroinflammation, a key feature of early AD pathology, suggesting that gut microbiota regulate the production of Aβ in the gut [94]. The gene discussed is APP; the disease is Alzheimer disease.